• Merck & Co., Inc. (MRK) Lands Chimerix, Inc.'s HIV Program in $168.5 Million Deal More...
• Galapagos NV (GLPG.BR) Delivers Candidate Drug in Osteoarthritis Alliance With Servier More...
• Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics, Inc. More...
• Catalent Pharma Solutions Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co., Ltd. and Extensive Investments to Its Zydis® Technology Capabilities in Swindon, UK More...
• Advinus Therapeutics (P) Ltd. and P2D Bioscience Enter into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD) More...
• Italy May Lose Thousands of Drug-Firm Jobs; Merck & Co., Inc. (MRK), Eli Lilly and Company (LLY) Amongst the Companies Mentioned More...
• Zogenix, Inc. Prices Public Offering of Common Stock and Warrants to Purchase Common Stock More...
• Relmada Therapeutics Raises $3.0 Million in Initial Closing of Series A Financing More...
• Blackstone Invests $125 Million in NantPharma, a NantWorks Company More...
• Histogenics Corporation Brings In $49 Million for Tissue Regeneration - and Recapitalization More...
• Plandai Biotechnology, Inc. (PLPL.OB) Receives $5.6 Million Initial Funding From the Land and Agriculture Bank of South Africa More...
• Owens & Minor (OMI) Plans to Purchase Movianto Group for $158 Million From Celesio AG More...
• Integra Group Bought by Ohio-based NAMSA More...
• Infinity Pharmaceuticals Inc. (INFI) Announces New Addition to Senior Leadership Team More...
• Quanticate Adds New Leadership to Oversee Expansion in Clinical Data Management and Pharmacovigilance More...
• Theorem Clinical Research Names Shannon Gordon Vice President of Global Project Management More...
• ADMA Biologics Appoints James Mond, M.D., Ph.D. as Chief Medical and Scientific Officer More...
• ADMA Biologics Appoints Plasma Industry LeaderLawrence Guiheen to Board of Directors More...
• Astex Pharmaceuticals (ASTX) to Announce 2012 Second Quarter Financial Results on July 30, 2012 More...
• Biogen Idec, Inc. (Massachusetts) (BIIB) Increases Revenue 18% to $1.4 Billion in the Second Quarter More...
• Flamel Technologies (FLML) Announces Projected Release Date of Second Quarter 2012 Results and Conference Call More...
• ICON Reports Second Quarter 2012 Revenue up 19% to $277 Million and Non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209) More...
• Repligen Corporation (RGEN) to Report Second Quarter of 2012 Financial Results More...
• Savient Pharmaceuticals, Inc. (SVNT) Receives Favorable Decision in Tang Capital Litigation More...
• BioLife Solutions, Inc. (BLFS.OB) Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite More...
• Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Alzheimer's Drug Fails Its First Big Trial More...
• Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT)'s Muscular Dystrophy Drug Improves With Time; Stock Soars More...
• Roche (RHHBY)'s Lucentis Works to Treat Vision Loss from Diabetes More...
• Biocryst Pharmaceuticals (BCRX) Reveals Favorable Results From Ulodesine in Phase II Clinical Trials More...
• Amarin Corporation PLC (AMRN) Announces Publication of ANCHOR Phase 3 Clinical Trial Results in The American Journal of Cardiology More...
• FDA Warns About Seizures With Acorda Therapeutics (ACOR)' MS Drug Ampyra More...
• FDA Approves Forest Laboratories, Inc. (FRX)' Tudorza Pressair More...
• Bioniche Life Sciences Inc. (BNC) Moves Closer to Market Launch of Immunocidin™ More...
• Dynavax Technologies Corporation (DVAX) Submits HEPLISAV for EU Marketing Authorization More...
• Medivation, Inc. (MDVN) Release: Enzalutamide Granted Priority Review by FDA for the Potential Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated With Chemotherapy More...
• Camargo Pharmaceutical Services Fast Tracks 505(b)(2) Indian Products More...
• Antioxidants Might Help Cut Pancreatic Cancer Risk, Gut Reveals More...
• Less Flavor But More Reward in Fatty Foods, University of Nottingham Study More...
• Improving Cognitive Function With Ginseng-Fortified Milk? IATA Study More...
• Aspirin Protects Against Barrett's Esophagus, Massachusetts General Hospital Study More...
• Is Youtube a Prescription for Vertigo? University of Michigan Health System Study More...
• Aegis Therapeutics, LLC Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants More...
• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Receives Patent on its Schisandra Lignin Extraction Method More...
• Egalet Announces Issuance of U.S. Patent More...
• Transgenomic, Inc. (TBIO) Announces Medicare Coverage for Clopidogrel (Plavix®) Response Test More...
• Galapagos NV (GLPG.BR) Delivers Candidate Drug in Osteoarthritis Alliance With Servier More...
• Vitro Biopharma Strengthens and Expands Its Distribution Agreement With Neuromics, Inc. More...
• Catalent Pharma Solutions Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co., Ltd. and Extensive Investments to Its Zydis® Technology Capabilities in Swindon, UK More...
• Advinus Therapeutics (P) Ltd. and P2D Bioscience Enter into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD) More...
• Italy May Lose Thousands of Drug-Firm Jobs; Merck & Co., Inc. (MRK), Eli Lilly and Company (LLY) Amongst the Companies Mentioned More...
• Zogenix, Inc. Prices Public Offering of Common Stock and Warrants to Purchase Common Stock More...
• Relmada Therapeutics Raises $3.0 Million in Initial Closing of Series A Financing More...
• Blackstone Invests $125 Million in NantPharma, a NantWorks Company More...
• Histogenics Corporation Brings In $49 Million for Tissue Regeneration - and Recapitalization More...
• Plandai Biotechnology, Inc. (PLPL.OB) Receives $5.6 Million Initial Funding From the Land and Agriculture Bank of South Africa More...
• Owens & Minor (OMI) Plans to Purchase Movianto Group for $158 Million From Celesio AG More...
• Integra Group Bought by Ohio-based NAMSA More...
• Infinity Pharmaceuticals Inc. (INFI) Announces New Addition to Senior Leadership Team More...
• Quanticate Adds New Leadership to Oversee Expansion in Clinical Data Management and Pharmacovigilance More...
• Theorem Clinical Research Names Shannon Gordon Vice President of Global Project Management More...
• ADMA Biologics Appoints James Mond, M.D., Ph.D. as Chief Medical and Scientific Officer More...
• ADMA Biologics Appoints Plasma Industry LeaderLawrence Guiheen to Board of Directors More...
• Astex Pharmaceuticals (ASTX) to Announce 2012 Second Quarter Financial Results on July 30, 2012 More...
• Biogen Idec, Inc. (Massachusetts) (BIIB) Increases Revenue 18% to $1.4 Billion in the Second Quarter More...
• Flamel Technologies (FLML) Announces Projected Release Date of Second Quarter 2012 Results and Conference Call More...
• ICON Reports Second Quarter 2012 Revenue up 19% to $277 Million and Non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209) More...
• Repligen Corporation (RGEN) to Report Second Quarter of 2012 Financial Results More...
• Savient Pharmaceuticals, Inc. (SVNT) Receives Favorable Decision in Tang Capital Litigation More...
• BioLife Solutions, Inc. (BLFS.OB) Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite More...
• Pfizer Inc. (PFE), Johnson & Johnson (JNJ) Alzheimer's Drug Fails Its First Big Trial More...
• Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT)'s Muscular Dystrophy Drug Improves With Time; Stock Soars More...
• Roche (RHHBY)'s Lucentis Works to Treat Vision Loss from Diabetes More...
• Biocryst Pharmaceuticals (BCRX) Reveals Favorable Results From Ulodesine in Phase II Clinical Trials More...
• Amarin Corporation PLC (AMRN) Announces Publication of ANCHOR Phase 3 Clinical Trial Results in The American Journal of Cardiology More...
• FDA Warns About Seizures With Acorda Therapeutics (ACOR)' MS Drug Ampyra More...
• FDA Approves Forest Laboratories, Inc. (FRX)' Tudorza Pressair More...
• Bioniche Life Sciences Inc. (BNC) Moves Closer to Market Launch of Immunocidin™ More...
• Dynavax Technologies Corporation (DVAX) Submits HEPLISAV for EU Marketing Authorization More...
• Medivation, Inc. (MDVN) Release: Enzalutamide Granted Priority Review by FDA for the Potential Treatment of Castration-Resistant Prostate Cancer in Patients Previously Treated With Chemotherapy More...
• Camargo Pharmaceutical Services Fast Tracks 505(b)(2) Indian Products More...
• Antioxidants Might Help Cut Pancreatic Cancer Risk, Gut Reveals More...
• Less Flavor But More Reward in Fatty Foods, University of Nottingham Study More...
• Improving Cognitive Function With Ginseng-Fortified Milk? IATA Study More...
• Aspirin Protects Against Barrett's Esophagus, Massachusetts General Hospital Study More...
• Is Youtube a Prescription for Vertigo? University of Michigan Health System Study More...
• Aegis Therapeutics, LLC Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants More...
• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Receives Patent on its Schisandra Lignin Extraction Method More...
• Egalet Announces Issuance of U.S. Patent More...
• Transgenomic, Inc. (TBIO) Announces Medicare Coverage for Clopidogrel (Plavix®) Response Test More...
0 comments